Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Núria Gendrau‐Sanclemente
Observed name:
Núria Gendrau-Sanclemente
Institutions:
Institut d'Investigació Biomédica de Bellvitge,
Institut Català d'Oncologia,
Duran i Reynals Hospital
Observed institutions:
Institut d'Investigació Biomédica de Bellvitge,
Institut Català d'Oncologia,
Duran i Reynals Hospital,
Universitat de Barcelona
ORCID:
0000-0002-7761-3695
Observed ORCID:
0000-0002-7761-3695
OpenAlex ID:
A5072073964
SGK1 is a signalling hub that controls protein synthesis and proliferation in endothelial cells
2020
·
Ferran Medina‐Jover
, Núria Gendrau‐Sanclemente
, et al.
·
FEBS Letters
·
23
PDF
Ovarian cancer relies on the PDGFRβ –fibronectin axis for tumorsphere formation and metastatic spread
2023
·
Núria Gendrau‐Sanclemente
, Agnès Figueras
, et al.
·
Molecular Oncology
·
18
KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer
2021
·
Débora Cabot
, Sònia Brun
, et al.
·
Oncogene
·
13
Author response for "Ovarian cancer relies on the PDGFRβ –fibronectin axis for tumorsphere formation and metastatic spread"
2023
·
Núria Gendrau‐Sanclemente
, Agnès Figueras
, et al.
·
Publons reviews and discussion
·
1
Sphingosine‐1‐Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis
2026
·
Núria Gendrau‐Sanclemente
, Agnès Figueras
, et al.
·
International Journal of Cancer
A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors
2026
·
Ferran Medina-Jover
, Agnès Figueras
, et al.
·
Biomedicine & Pharmacotherapy
Abstract 1553: S1PR1 directs tumorsphere proliferation in ovarian cancer
2024
·
Núria Gendrau-Sanclemente
, Agnès Figueras
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
55
H-index:
3
I10-index:
3
Year
Topic
Type